• Onto Innovation recently drew attention as investors reacted to progress on its AI-driven advanced packaging roadmap, including approaching initial Dragonfly G5 system shipments, alongside sector-wide strength in semiconductor equipment names.
• At the same time, its collaboration and planned ownership stake with Rigaku have highlighted Onto Innovation’s role in next-generation process control solutions for advanced chip manufacturing.
• Next, we’ll explore how renewed optimism around Onto’s AI-focused Dragonfly G5 platform could influence the company’s existing investment narrative.

AI is about to change healthcare. These 39 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

Onto Innovation Investment Narrative Recap

To own Onto Innovation, you need to believe in its role at the heart of AI-driven advanced packaging and process control, particularly around Dragonfly G5 and Semilab-enabled metrology. The recent share move on AI packaging optimism reinforces that the near term story still hinges on a healthy Q4 and 2026 spending recovery, while the biggest current risk remains any delay or softness in advanced packaging and AI node demand. So far, this news does not fundamentally change that balance.

Among recent announcements, the collaboration and planned 27% stake in Rigaku stands out as most relevant. By combining Onto’s AI Diffract software with Rigaku’s X-ray platforms, the company is positioning itself more firmly in next generation process control for complex AI chips. For investors focused on catalysts, this Rigaku tie up sits alongside Dragonfly G5 qualifications and Semilab integration as part of a broader effort to deepen Onto’s role in critical high value inspection and metrology workflows.

Yet against this optimism around AI packaging and new tools, investors should be aware of how quickly concentrated customer demand could turn if...

Onto Innovation's narrative projects $1.9 billion revenue and $590.6 million earnings by 2029.

Uncover how Onto Innovation's forecasts yield a $352.14 fair value, a 27% upside to its current price.

Exploring Other Perspectives

Some of the most optimistic analysts saw Onto reaching about US$1.8 billion in revenue and US$710 million in earnings by 2029, which paints a much rosier path than consensus and assumes AI packaging momentum and process control wins keep compounding well beyond what this week’s news, or concerns about customer concentration, currently reflect.

Explore 5 other fair value estimates on Onto Innovation - why the stock might be worth as much as 37% more than the current price!

Form Your Own Verdict

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your Onto Innovation research is our analysis highlighting 2 key rewards and 2 important warning signs that could impact your investment decision.
• Our free Onto Innovation research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Onto Innovation's overall financial health at a glance.

Interested In Other Possibilities?

The market won't wait. These fast-moving stocks are hot now. Grab the list before they run:

• Capitalize on the AI infrastructure supercycle with our selection of the 47 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
• We've uncovered the 11 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.
• The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 14 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.